Quick Answer
CNBX Pharmaceuticals Inc. reported Cash And Cash Equivalents At Carrying Value of $15.1 thousand for the year ending 2025.
- CNBX Pharmaceuticals Inc. showed a decrease of -42.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 1, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2004: $0.00 | Q2 2013: $14.00 | Q4 2013: $31.4 thousand | Q1 2014: $1.1 thousand | Q2 2014: $0.00 | Q4 2014: $65.6 thousand | Q1 2015: $8.2 thousand | Q2 2015: $21.6 thousand | Q4 2015: $9.6 thousand | Q1 2016: $77.4 thousand | Q2 2016: $88.5 thousand | Q4 2016: $278.2 thousand | Q1 2017: $567.2 thousand | Q2 2017: $3.19 million | Q4 2017: $2.89 million | Q1 2018: $2.86 million | Q2 2018: $2.22 million | Q4 2018: $6.58 million | Q1 2019: $5.17 million | Q2 2019: $493.5 thousand | Q4 2019: $319.3 thousand | Q1 2020: $587.0 thousand | Q2 2020: $357.6 thousand | Q3 2020: $777.6 thousand | Q4 2020: $184.0 thousand | Q1 2021: $1.33 million | Q2 2021: $1.97 million | Q4 2021: $786.4 thousand | Q1 2022: $231.6 thousand | Q2 2022: $96.3 thousand | Q4 2022: $21.6 thousand | Q1 2023: $47.7 thousand | Q2 2023: $44.2 thousand | Q4 2023: $81.6 thousand | Q1 2024: $37.1 thousand | Q2 2024: $73.4 thousand | Q4 2024: $17.3 thousand | Q1 2025: $45.7 thousand | Q2 2025: $13.6 thousand | Q3 2025: $15.1 thousand | Q4 2025: $7.7 thousand.
- Historical annual values: Fiscal year 2025: $15.1 thousand | Fiscal year 2024: $26.4 thousand | Fiscal year 2023: $129.7 thousand | Fiscal year 2022: $117.5 thousand | Fiscal year 2021: $1.39 million | Fiscal year 2020: $777.6 thousand | Fiscal year 2019: $266.0 thousand | Fiscal year 2018: $1.39 million | Fiscal year 2017: $1.39 million | Fiscal year 2016: $19.1 thousand | Fiscal year 2015: $25.2 thousand | Fiscal year 2014: $98.8 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: